GLP1R and ischemic stroke: investigated the association of genetic proxies for targets of sulfonylureas, insulin analogues, GLP-1 agonists (also approved for weight loss), and thiazolidinediones on ischemic stroke risk.113 Variants were selected according to associations with blood glucose in non-diabetic participants in the UK Biobank.